News-Medical.Net October 7, 2025
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over 15,000 women a year, say scientists at the University of Cambridge.
In 2022, 2.3 million women were diagnosed with breast cancer worldwide and there were 670,000 related deaths. Despite significant progress in recent years, it remains challenging to accurately identify the best treatments for individual patients and to predict cases with poorer prognosis.
Whole genome sequencing is a powerful technique that involves analysing the DNA of both the patient and their tumour to look for genetic changes, or mutations. This provides information on the underlying cause of the tumour and...
Today's Sponsors
Today's Sponsor